Thousands of women in the UK with diabetes are currently experiencing menopause. But at the moment, the advice and support for managing the condition through the menopause just isn’t there.

Last year, the Diabetes Data Science Catalyst launched to advance data research into heart disease and diabetes. Now, the first projects of the initiative are getting off the ground.

Eye damage caused by diabetes is called retinopathy. If left unchecked, it can lead to vision problems and eventually sight loss. But treatment options are currently limited, invasive, and don’t work for everyone.

Our vision of world where diabetes can do no harm can only be reached by investing in ground-breaking research.

Diabetes stigma refers to negative thoughts, attitudes and behaviours towards people living with diabetes.

Each year we invest over £6 million into all kinds of new research, investigating everything from the root causes of diabetes to its complications. Now let’s shine the spotlight on a project that’s just underway. 

We’ve taken some of the cutting-edge science we fund out of the lab and into the pub. As part of the Pint of Science festival, two of our brilliant researchers at the University of Exeter gave pub-goers a run through of their latest Diabetes UK-funded work. 

We’re shining the spotlight on a research project we’re co-funding with the National Institute for Health and Care Research (NIHR), looking at how dentist appointments could help to find people with or at risk of type 2 diabetes.

A blood pressure treatment called verapamil can protect insulin-making beta cells, slowing down type 1 diabetes progression in young people, according to the results of a new clinical trial funded by JDRF.

In a new study funded by us, researchers have discovered new information about the role of a molecule found in chillis in reducing foot pain by healing damaged nerves.